Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Mental disorder, Myalgia, Oropharyngeal discomfort, Pain in extremity, Product dose omission issue
Clinical narrative: Did not receive the second dose; Felt it in my joints more; Muscle underneath where received shot really hurts/muscle pain; Itchy, red bumps at the injection/little raised and looks kind of like a hive; Groggy; Arm hurting; Lost her mind like a loose cannon; Bawling; Maniac; Emotional; Felt like crying; Face bit swollen; Spot is swollen red hot to touch and itchy; Red spot at the injection site/spot is swollen red hot to touch and itchy/red, itchy spot; Spot is swollen red hot to touch and itchy; Throat hurt and little swollen; Spot is swollen red hot to touch and itchy/red, itchy spot; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose), PAIN IN EXTREMITY (Sore arm), MENTAL DISORDER (Lost her mind like a loose cannon), CRYING (Bawling) and MANIA (Maniac) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Ehlers-Danlos syndrome. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR [VALACICLOVIR HYDROCHLORIDE]) for an unknown indication.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 30-Apr-2021, the patient experienced MENTAL DISORDER (Lost her mind like a loose cannon), CRYING (Bawling), MANIA (Maniac), EMOTIONAL DISORDER (Emotional), DEPRESSED MOOD (Felt like crying), SWELLING FACE (Face bit swollen), PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE WARMTH (Spot is swollen red hot to touch and itchy), OROPHARYNGEAL DISCOMFORT (Throat hurt and little swollen), VACCINATION SITE PRURITUS (Spot is swollen red hot to touch and itchy/red, itchy spot), VACCINATION SITE SWELLING (Spot is swollen red hot to touch and itchy) and VACCINATION SITE ERYTHEMA (Red spot at the injection site/spot is swollen red hot to touch and itchy/red, itchy spot). On 01-May-2021, the patient experienced SOMNOLENCE (Groggy). On 21-Jun-2021, the patient experienced VACCINATION SITE URTICARIA (Itchy, red bumps at the injection/little raised and looks kind of like a hive). On 24-Jun-2021, the patient experienced MYALGIA (Muscle underneath where received shot really hurts/muscle pain). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose) and CONDITION AGGRAVATED (Felt it in my joints more). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swelling face, at a dose of UNK dosage form. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not receive the second dose), PAIN IN EXTREMITY (Sore arm), MENTAL DISORDER (Lost her mind like a loose cannon), CRYING (Bawling), MANIA (Maniac), EMOTIONAL DISORDER (Emotional), DEPRESSED MOOD (Felt like crying), SWELLING FACE (Face bit swollen), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE WARMTH (Spot is swollen red hot to touch and itchy) and VACCINATION SITE SWELLING (Spot is swollen red hot to touch and itchy) had resolved and CONDITION AGGRAVATED (Felt it in my joints more), OROPHARYNGEAL DISCOMFORT (Throat hurt and little swollen), VACCINATION SITE PRURITUS (Spot is swollen red hot to touch and itchy/red, itchy spot), VACCINATION SITE URTICARIA (Itchy, red bumps at the injection/little raised and looks kind of like a hive), VACCINATION SITE ERYTHEMA (Red spot at the injection site/spot is swollen red hot to touch and itchy/red, itchy spot) and MYALGIA (Muscle underneath where received shot really hurts/muscle pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received and added current medical condition, concomitant medication and new events. Updated action taken and outcome of events.